TP63 and neoplasm: This study concluded that basal tumours with KRT5/6, p63, and KRT14 expression had a better response to chemotherapy, while luminal tumours with active PPAR expression and activating mutations in FGFR3 showed expression of KRT20, FOXA1, and GATA3.